Company Profile

Kestrel Labs Inc
Profile last edited on: 2/17/22      CAGE: 3DRU1      UEI: VT6HK9MLF2Y9

Business Identifier: Medical electronics enterprise: medical device testing, contract research, design and engineering services
Year Founded
2001
First Award
2003
Latest Award
2021
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

3133 Indian Road Suite K
Boulder, CO 80301
   (303) 544-0660
   busdev@kestrellabs.com
   www.kestrellabs.com
Location: Single
Congr. District: 02
County: Boulder

Public Profile

In December 2021 it was announced that Kestrel Labs, Inc. had been acquired - in a $31,000,000 transaction - by Zynex (NASDAQ:ZYXI) Kestrel medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring. Kestrel had been a medical electronics company addressing the task of solving major challenges in the field of pulse oximetry. Bringing together decades of experience in the medical device industry - included one of original members of BIOX, the company that developed the first commercially-viable pulse oximeter - Kestrel also undertook contract research, design, and engineering services in the areas of: * Medical instrumentation, * Spectrophotometry and photoplethysmography, * Analog and digital hardware, * Embedded systems software, * Optical, mechanical, and opto-mechanical systems and * Injection molded parts. The company also provides expert witness work for product safety and intellectual property disputes in the areas of : pulse oximetry, photoplethysmography, and noninvasive medical monitoring.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
5-9

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2021 2 NIH $1,663,179
Project Title: Noninvasive Total Hemoglobin Monitor
2016 1 NIH $150,000
Project Title: Pulse Oximeter Innovation to Measure Pulsus Paradoxus and Respiratory Disease Severity
2009 2 NIH $3,850,371
Project Title: Pulse CO-Oximeter for Multiple Hemoglobin Species
2006 2 NIH $1,120,487
Project Title: Spiral Electrode Sensor for Intrapartum Fetal Oximetry

Key People / Management

  Jonas A Pologe -- Co-Founder, Chief Executive Officer

  Ted Delianides -- Co-Founder, Chief Operating Officer

  David R Tobler

  Adriaan Verheij -- Principal Software Design Engineer

Company News

There are no news available.